KMB Kimberly-Clark Corporation

-

Kimberly-Clark Reported In-line with Expectations

Thursday, November 5, 2026 · 6:30 AM ET

Kimberly-Clark (KMB) reported earnings of $1.70 per share on revenue of $4.13 billion for the third quarter ended September 2026. The consensus earnings estimate was $1.69 per share on revenue of $4.15 billion. The Earnings Whisper number was $1.70 per share. The company reported in-line with expectations while revenue fell 0.39% compared to the same quarter a year ago.

Kimberly-Clark and its trusted brands are an indispensable part of life for people in more than 175 countries.

Earnings Whisper Grade
Power Rating
Reported Earnings
$1.70
Earnings Whisper®
$1.70
Consensus Estimate
$1.69
Earnings Surprise
Earnings Growth-6.6 %
Reported Revenue
$4.13B
Revenue Estimate
$4.15B
Revenue Surprise
Revenue Growth-0.4 %

*Reported earnings and revenue figures shown above, and any guidance given, are preliminary and may be updated upon further review.*

Kimberly-Clark Third Quarter 2026 Financial Results Available on Company's Investor Relations Website

Thursday, November 5, 2026 · 6:30 AM ET PR Newswire

DALLAS, Nov. 5, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark"), a core S&P 500 component, today announced its third quarter 2026 financial results. The earnings release and supplemental materials are available at investor.kimberly-clark.com. The earnings release will be furnished to the Securities and Exchange Commission on a Form 8-K. The Company will host a live Q&A session with analysts at 8:00 a.m. EST.

Logo: Kimberly-Clark Corporation

Conference Call and Webcast Details

Kimberly-Clark's live Q&A session and related materials can be accessed at investor.kimberly-clark.com. A replay of the webcast will be available following the event through the same website.

About Kimberly-Clark

Kimberly-Clark (NASDAQ: KMB) is the preeminent global health and wellness leader, built to deliver extraordinary care. Our portfolio of iconic personal care and consumer health brands, including Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson's Baby, Kotex and Scott, serves consumers across every stage of life in more than 175 countries. We combine consumer-led innovation, leading brand-building and commercial capabilities, and a fast and agile operating model to raise the standard of care for billions of people around the world. We are committed to using sustainable practices designed to support a healthy planet, build strong communities, and enable our business to thrive for decades to come. The KMB stock is a large cap growth and value stock and core S&P 500 equity held by more than 400 Exchange Traded Funds. Kimberly-Clark is considered a Dividend Aristocrat, having paid a dividend for 92 consecutive years and increasing its dividend in each of the past 54 consecutive years. To keep up with the latest news and learn more about the company's more than 150-year history, visit the Kimberly-Clark website.

[KMB-F] [KMB-C]

Contacts

Investor Relations:
Christopher Jakubik, CFA
KC.InvestorRelations@kcc.com 

Media Relations:
Kyrsten Aspegren
media.relations@kcc.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kimberly-clark-third-quarter-2026-financial-results-available-on-companys-investor-relations-website-302929702.html

SOURCE Kimberly-Clark Corporation